{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:15:58Z","timestamp":1766268958569,"version":"3.40.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Ministry of Science and Technology","award":["106-2320-B-038-018"],"award-info":[{"award-number":["106-2320-B-038-018"]}]},{"name":"Ministry of Science and Technology","award":["108-2320-B-038-041"],"award-info":[{"award-number":["108-2320-B-038-041"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>In 2013, the U.S. Food and Drug Administration issued a safety warning that cautioned against using magnesium sulfate (MgSO<jats:sub>4<\/jats:sub>) injections for more than 5 to 7\u200adays to stop preterm delivery due to the bone problems subsequently observed in infants. However, the warning was mainly based on case reports, and further investigation is necessary to determine whether prolonged MgSO<jats:sub>4<\/jats:sub> use increased infant fractures.<\/jats:p>\n            <jats:p>To evaluate whether prolonged MgSO<jats:sub>4<\/jats:sub> use for tocolysis increased the risk of subsequent fractures among infants.<\/jats:p>\n            <jats:p>A retrospective population-based cohort study was conducted with a new-user study design using the National Health Insurance Database in Taiwan. We included pregnant women aged between 12 and 55\u200ayears old who delivered a live-born singleton. The enrollment period was from January 1, 2012 to December 31, 2014. The exposure group was defined as pregnant women who received MgSO<jats:sub>4<\/jats:sub> injection for &gt;5 days during pregnancy, while those not receiving any tocolytics were the reference group. The outcome was any bone fracture among the infants during the 2-year follow-up period. Propensity score matching and Cox proportional hazards regression models were used to estimate the hazard of fractures. We further studied the effect of MgSO<jats:sub>4<\/jats:sub> treatment with varied dosages and durations of treatment in the sensitivity analyses.<\/jats:p>\n            <jats:p>Among the 4092 pregnant women in the database, 693 (16.9%) of them were included in the exposure group. The hazard ratio of infant fractures among prolonged MgSO<jats:sub>4<\/jats:sub> users was not significantly different from that of tocolytic nonusers in adjusted models (adjusted hazard ratio (aHR)\u200a=\u200a1.48; 95% confidence interval (CI)\u200a=\u200a0.59\u20133.71). A similar lack of significance was found in the sensitivity analyses (aHR\u200a=\u200a1.45; 95% CI\u200a=\u200a0.40\u20135.28 for larger treatment dosage; aHR\u200a=\u200a2.52; 95% CI\u200a=\u200a0.49\u201312.98 for longer treatment duration).<\/jats:p>\n            <jats:p>Prolonged MgSO<jats:sub>4<\/jats:sub> tocolysis use did not increase the risk of infant fractures. Our findings reconfirmed the safety of MgSO<jats:sub>4<\/jats:sub> as a tocolytic treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028310","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T19:37:53Z","timestamp":1640288273000},"page":"e28310","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Association between the prolonged use of magnesium sulfate for tocolysis and fracture risk among infants"],"prefix":"10.1097","volume":"100","author":[{"given":"Yung-Hsiang","family":"Wen","sequence":"first","affiliation":[{"name":"School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Te","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Ju","family":"Lin","sequence":"additional","affiliation":[{"name":"Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan"},{"name":"School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan"},{"name":"Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsing-Yu","family":"Hsu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0495-1922","authenticated-orcid":false,"given":"Chung-Hsuen","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2471\/BLT.08.062554","article-title":"The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity","volume":"88","author":"Beck","year":"2010","journal-title":"Bull World Health Organ"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","article-title":"National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications","volume":"379","author":"Blencowe","year":"2012","journal-title":"Lancet"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1136\/bmj.e6226","article-title":"Tocolytic therapy for preterm delivery: systematic review and network meta-analysis","volume":"345","author":"Haas","year":"2012","journal-title":"BMJ"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1001\/jama.290.20.2669","article-title":"Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial","volume":"290","author":"Crowther","year":"2003","journal-title":"JAMA"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-0528.2006.01162.x","article-title":"Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial\u2217","volume":"114","author":"Marret","year":"2007","journal-title":"BJOG"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa0801187","article-title":"A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy","volume":"359","author":"Rouse","year":"2008","journal-title":"N Engl J Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ajcp\/102.5.616","article-title":"Magnesium: the fifth but forgotten electrolyte","volume":"102","author":"Elin","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.ajog.2005.11.045","article-title":"Effect of magnesium sulfate on contractile force and intracellular calcium concentration in pregnant human myometrium","volume":"194","author":"Fomin","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/AOG.0b013e31817c50fc","article-title":"Obstetrician-gynecologists\u2019 screening and management of preterm birth","volume":"112","author":"Morgan","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1006\/bbrc.1998.9680","article-title":"Cellular mechanisms underlying magnesium sulfate inhibition of phasic myometrial contractions","volume":"252","author":"Phillippe","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/CS20070129","article-title":"Cell (patho)physiology of magnesium","volume":"114","author":"Wolf","year":"2008","journal-title":"Clin Sci"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1515\/JPEM.2006.19.10.1225","article-title":"Osteopenic effects of MgSO4 in multiple pregnancies","volume":"19","author":"Kaplan","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00247-004-1148-1","article-title":"Bone mineralization in newborns whose mothers received magnesium sulphate for tocolysis of premature labour","volume":"34","author":"Malaeb","year":"2004","journal-title":"Pediatr Radiol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.jp.7211508","article-title":"Skeletal demineralization and fractures caused by fetal magnesium toxicity","volume":"26","author":"Wedig","year":"2006","journal-title":"J Perinatol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.earlhumdev.2010.02.007","article-title":"Prolonged maternal magnesium administration and bone metabolism in neonates","volume":"86","author":"Yokoyama","year":"2010","journal-title":"Early Hum Dev"},{"key":"R18-20250504","first-page":"611","article-title":"Magnesium tocolysis and neonatal bone abnormalities: a controlled study","volume":"78","author":"Holcomb","year":"1991","journal-title":"Obstet Gynecol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000291492","article-title":"Effect of magnesium sulfate treatment on neonatal bone abnormalities","volume":"44","author":"Matsuda","year":"1997","journal-title":"Gynecol Obstet Invest"},{"key":"R20-20250504","first-page":"595","article-title":"Effects of magnesium sulfate treatment on perinatal calcium metabolism. II. Neonatal responses","volume":"56","author":"McGuinness","year":"1980","journal-title":"Obstet Gynecol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/00016340600756896","article-title":"Adverse maternal and neonatal outcome of prolonged course of magnesium sulfate tocolysis","volume":"85","author":"Nassar","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000291864","article-title":"Effects of long-term maternal intravenous magnesium sulfate therapy on neonatal calcium metabolism and bone mineral content","volume":"43","author":"Schanler","year":"1997","journal-title":"Gynecol Obstet Invest"},{"key":"R26-20250504","first-page":"209","article-title":"Set-up and future applications of the Taiwan Maternal and Child Health Database (TMCHD)","volume":"35","author":"Li","year":"2016","journal-title":"Taiwan J Public Health"},{"key":"R27-20250504","first-page":"01","article-title":"Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour","volume":"12","author":"McNamara","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"year":"2001","key":"R29-20250504","article-title":"Reducing Bias in a Propensity Score Matched-Pair Sample Using Greedy Matching Techniques. Proceedings of the Twenty-sixth Annual SAS Users Group International Conference"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application","volume":"2","author":"Lund","year":"2015","journal-title":"Curr Epidemiol Rep"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/pds.1926","article-title":"A basic study design for expedited safety signal evaluation based on electronic healthcare data","volume":"19","author":"Schneeweiss","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrrheum.2015.30","article-title":"Active-comparator design and new-user design in observational studies","volume":"11","author":"Yoshida","year":"2015","journal-title":"Nat Rev Rheumatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028310","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:06:48Z","timestamp":1746338808000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":27,"journal-issue":{"issue":"51","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028310","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,12,23]]},"assertion":[{"value":"2021-06-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}